Prodrug of 5-FU and inhibitor of thymidylate synthase that is used to treat various cancers. It inhibits DNA synthesis, Each
$ 126.92
|
|
Details
Capecitabine is an antifolate anticancer chemotherapeutic that acts as a prodrug of 5-fluorouracil (5-FU), a fluoropyrimidine carbamate that inhibits thymidylate synthase. Capecitabine is converted to 5-FU by thymidine phosphorylase in vivo. Capecitabine displays varying efficacy in the treatment of colorectal, metastatic breast, prostate, ovarian, and pancreatic cancers.
Additional Information
| SKU | 5583867 |
|---|---|
| UOM | Each |
| UNSPSC | 12352200 |
| Manufacturer Part Number | C0162-250 mg |
| CAS Number | 154361-50-9 |
| HS Code | 2934999000 |
|---|---|
| UN Number | NULL |
| Proper Shipping Name | CAPECITABINE |
| EC Number | 604-948-1 |
| Risk Statements | 45-60-61-68 |
| Safety Statements | 53-22-36/37-45 |
| Hazard Code | T |
Loading Cart Data 